Zevra Therapeutics (ZVRA) Preferred Dividend Payments (2021)
Zevra Therapeutics (ZVRA) reported Preferred Dividend Payments of $16.9 million for Q2 2021, down 54.87% quarter-over-quarter from $37.4 million in Q1 2021.
Zevra Therapeutics (ZVRA) Preferred Dividend Payments (2021) Analysis & Trends
Zevra Therapeutics has reported Preferred Dividend Payments for 1 years, with the latest figure at $16.9 million in Q2 2021.
- For the quarter ending Q2 2021, Preferred Dividend Payments changed N/A year-over-year to $16.9 million; the trailing twelve-month figure through Mar 2022 stood at $16.9 million (down 54.87% YoY), and the FY2021 full-year result was $54.3 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q2 2021 stood at $16.9 million, down from $37.4 million in the prior quarter.
- The five-year high for Preferred Dividend Payments was $37.4 million in Q1 2021, with the low at $16.9 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Zevra Therapeutics | 704.96 Mn | 504.34 Mn | 34.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 16.90 Mn |
| Mar 31, 2021 | 37.44 Mn |